Rn. Josserand et al., Cystic fibrosis phenotype evaluation and paternity outcome in 50 males with congenital bilateral absence of vas deferens, HUM REPR, 16(10), 2001, pp. 2093-2097
BACKGROUND: Most infertile males with congenital bilateral absence of vas d
eferens; (CBAVD) carry mutations on the cystic fibrosis transmembrane condu
ctance regulator gene and may express mild cystic fibrosis (CF) symptoms. B
arriers to paternity for these men can now be overcome by assisted reproduc
tion. Our aims were to investigate the CF-related phenotype and clinical ou
tcome for 50 patients with CBAVD seen at a CF adult centre between 1992 and
1999. METHODS AND RESULTS: The investigation of the patients included scre
ening for 22 CF mutations and identification of the poly-T variant of intro
n 8, sweat testing, clinical investigation for CF-related extra-genital man
ifestations, and genetic counselling. CFTR mutations were detected on 56 al
leles of the 50 patients. A total of 15 (30%) was compound heterozygote and
26 (52%) heterozygote. In all, 38% of the patients had a positive sweat te
st. Four patients were diagnosed with typical CIT not detected previously.
Twenty-one patients became fathers following ICSI (eight cases), artificial
insemination by donor or IVF with sperm donor (seven cases) or through ado
ption (six cases). A mail survey allowed the identification of CF-related c
linical symptoms. Information on the occurrence of CF-related symptoms was
obtained for 58.5% of patients: in the absence of initial symptoms, no new
clinical signs were reported. CONCLUSION: Patients diagnosed with CBAVD nee
d genetic counselling before assisted reproduction. Even when no wish for p
aternity is expressed, CF gene screening should be associated with at least
a sweat test and clinical evaluation because of possible mild forms of CF
disease. Medical follow-up did not reveal any new symptoms.